Legal & General Group PLC Oncorus, Inc. Transaction History

Legal & General Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.85 - $1.65 $1,384 - $2,687	-1,629 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$13.3 - $17.3 $12,754 - $16,590	959 Added 143.13%	1,629 $22,000
Q4 2020 Feb 12, 2021	BUY	$15.0 - $35.15 $10,050 - $23,550	670 New	670 $22,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.